Shrydus Industries Ltd
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
- Market Cap ₹ 18.5 Cr.
- Current Price ₹ 5.79
- High / Low ₹ 29.0 / 3.78
- Stock P/E 35.6
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding is low: 25.9%
- Promoter holding has decreased over last 3 years: -14.0%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | |
|---|---|---|---|---|
| 0.34 | 0.53 | 0.45 | 9.45 | |
| 0.57 | 0.61 | 0.53 | 8.93 | |
| Operating Profit | -0.23 | -0.08 | -0.08 | 0.52 |
| OPM % | -67.65% | -15.09% | -17.78% | 5.50% |
| 0.01 | 0.02 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.00 |
| Profit before tax | -0.26 | -0.10 | -0.12 | 0.52 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% |
| -0.26 | -0.10 | -0.12 | 0.52 | |
| EPS in Rs | 0.16 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 32% |
| 3 Years: | 36% |
| 1 Year: | -67% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | |
|---|---|---|---|---|
| Equity Capital | 6.35 | 6.35 | 6.35 | |
| Reserves | -2.60 | -2.69 | -2.81 | |
| 3.42 | 3.42 | 3.42 | ||
| 0.23 | 0.25 | 0.27 | ||
| Total Liabilities | 7.40 | 7.33 | 7.23 | |
| 0.52 | 0.49 | 0.45 | ||
| CWIP | 0.00 | 0.00 | 0.00 | |
| Investments | 2.91 | 2.27 | 2.27 | |
| 3.97 | 4.57 | 4.51 | ||
| Total Assets | 7.40 | 7.33 | 7.23 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | |
|---|---|---|---|---|
| Net Cash Flow |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2003 | Mar 2004 | Mar 2005 | Mar 2024 | |
|---|---|---|---|---|
| Debtor Days | 2,286.62 | 1,246.51 | 1,476.22 | |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 2,286.62 | 1,246.51 | 1,476.22 | |
| Working Capital Days | 4,004.26 | 2,975.09 | 3,422.89 | |
| ROCE % | -1.40% | -1.71% |
Documents
Announcements
-
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
22 Apr - Company confirms not a 'Large Corporate' and no debt securities per SEBI circular.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
22 Apr - Confirms Shrydus Industries is not a Large Corporate and holds no debt securities per SEBI norms.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 4 Apr
- Closure of Trading Window 29 Mar
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
25 Mar - Intimation of duplicate share certificates issuance.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector